Bitcoin halving
What does that mean?
$2.78T
Total marketcap
$105.22B
Total volume
BTC 49.61%     ETH 15.29%
Dominance

Lonza Group AG LZAGY Stock

59.91 USD {{ price }} 0.807672% {{change_pct}}%
Exchange
Other OTC
Market Cap
44.5B USD
LOW - HIGH [24H]
59.67 - 60.12 USD
VOLUME [24H]
462.66K USD
{{ volume }}
P/E Ratio
35.44
Earnings per share
1.69 USD

Lonza Group AG Price Chart

Lonza Group AG LZAGY Financial and Trading Overview

Lonza Group AG stock price 59.91 USD
Previous Close 63.1 USD
Open 62.11 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 62.11 - 63.47 USD
52 Week Range 43.85 - 66 USD
Volume 137.03K USD
Avg. Volume 56.84K USD
Market Cap 47.11B USD
Beta (5Y Monthly) 0.622222
PE Ratio (TTM) 35.233334
EPS (TTM) 1.69 USD
Forward Dividend & Yield 0.39 (0.61%)
Ex-Dividend Date May 9, 2023
1y Target Est N/A

LZAGY Valuation Measures

Enterprise Value 47.3B USD
Trailing P/E 35.233334
Forward P/E 2.9401946
PEG Ratio (5 yr expected) 0.15
Price/Sales (ttm) 7.5702057
Price/Book (mrq) 4.4455347
Enterprise Value/Revenue 7.601
Enterprise Value/EBITDA 24.922

Trading Information

Lonza Group AG Stock Price History

Beta (5Y Monthly) 0.622222
52-Week Change 24.47%
S&P500 52-Week Change 20.43%
52 Week High 66 USD
52 Week Low 43.85 USD
50-Day Moving Average 63.66 USD
200-Day Moving Average 55.91 USD

LZAGY Share Statistics

Avg. Volume (3 month) 56.84K USD
Avg. Daily Volume (10-Days) 117.79K USD
Shares Outstanding 742.82M
Float 742.13M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.14%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 3.5
Trailing Annual Dividend Yield 5.54%
5 Year Average Dividend Yield 57.99%
Payout Ratio 0.1768
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 19.52%
Operating Margin (ttm) 22.28%
Gross Margin 39.17%
EBITDA Margin 30.50%

Management Effectiveness

Return on Assets (ttm) 5.12%
Return on Equity (ttm) 11.89%

Income Statement

Revenue (ttm) 6.22B USD
Revenue Per Share (ttm) 8.38 USD
Quarterly Revenue Growth (yoy) 13.00%
Gross Profit (ttm) 2.44B USD
EBITDA 1.9B USD
Net Income Avi to Common (ttm) 1.22B USD
Diluted EPS (ttm) 1.8
Quarterly Earnings Growth (yoy) -72.50%

Balance Sheet

Total Cash (mrq) 2.22B USD
Total Cash Per Share (mrq) 2.99 USD
Total Debt (mrq) 2.59B USD
Total Debt/Equity (mrq) 24.26 USD
Current Ratio (mrq) 1.856
Book Value Per Share (mrq) 14.266

Cash Flow Statement

Operating Cash Flow (ttm) 1.02B USD
Levered Free Cash Flow (ttm) -988249984 USD

Profile of Lonza Group AG

Country United States
State N/A
City Basel
Address Muenchensteinerstrasse 38
ZIP 4002
Phone 41 61 316 81 11
Website https://www.lonza.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 17494

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. It supports customers across various aspects of design, development, and manufacturing. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. In addition, this segment provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. The company was incorporated in 1897 and is headquartered in Basel, Switzerland.

Q&A For Lonza Group AG Stock

What is a current LZAGY stock price?

Lonza Group AG LZAGY stock price today per share is 59.91 USD.

How to purchase Lonza Group AG stock?

You can buy LZAGY shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Lonza Group AG?

The stock symbol or ticker of Lonza Group AG is LZAGY.

Which industry does the Lonza Group AG company belong to?

The Lonza Group AG industry is Diagnostics & Research.

How many shares does Lonza Group AG have in circulation?

The max supply of Lonza Group AG shares is 742.82M.

What is Lonza Group AG Price to Earnings Ratio (PE Ratio)?

Lonza Group AG PE Ratio is 35.44970300 now.

What was Lonza Group AG earnings per share over the trailing 12 months (TTM)?

Lonza Group AG EPS is 1.69 USD over the trailing 12 months.

Which sector does the Lonza Group AG company belong to?

The Lonza Group AG sector is Healthcare.